Article Information
History
- July 27, 2021.
Article Versions
- Version 1 (July 16, 2021 - 10:22).
- You are currently viewing Version 2 of this article (July 27, 2021 - 08:25).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Anastasia A. Minervina1,#,
- Mikhail V. Pogorelyy1,#,
- Allison M. Kirk1,
- E. Kaitlynn Allen1,
- Kim J. Allison2,
- Chun-Yang Lin1,
- David C. Brice1,
- Xun Zhu3,
- Kasi Vegesana4,
- Gang Wu3,
- Jeremy Chase Crawford1,
- Stacey Schultz-Cherry2,
- Jeremie H. Estepp5,
- Maureen A. McGargill1,
- the SJTRC Study Team✤,
- Joshua Wolf2,* and
- Paul G. Thomas1,*
- 1Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN USA
- 2Department of Infectious Diseases, St. Jude Children’s Research Hospital, Memphis, TN USA
- 3Center for Applied Bioinformatics, St. Jude Children’s Research Hospital, Memphis, TN USA
- 4Information Services, St. Jude Children’s Research Hospital, Memphis, TN USA
- 5Department of Global Pediatric Medicine, St. Jude Children’s Research Hospital, Memphis, TN USA
- ↵*Correspondence to Joshua Wolf joshua.wolf{at}stjude.org and Paul Thomas paul.thomas{at}stjude.org
↵# Equal contribution
Posted July 27, 2021.
Convergent epitope-specific T cell responses after SARS-CoV-2 infection and vaccination
